alexa Therapeutic advantage of grid irradiation for large single fractions.


Journal of Cancer Science & Therapy

Author(s): Zwicker RD, Meigooni A, Mohiuddin M, Zwicker RD, Meigooni A, Mohiuddin M

Abstract Share this page

Abstract PURPOSE: In the present work, we used model calculations of cell survival to compare the effects of single fraction high-dose grid therapy with those of uniform dose delivery on tumor and normal tissues. METHODS AND MATERIALS: The grid consisted of a hexagonal pattern of divergent holes in a Cerrobend block. A linear-quadratic model was used to find the surviving fraction of tumor and normal tissue cells after high-dose irradiation. Equivalent uniform doses were determined according to the tumor cell kill. The ratio of the normal tissue surviving fraction under grid irradiation to that obtained under equivalent uniform dose irradiation was taken as a measure of therapeutic gain. RESULTS: The therapeutic ratio varied from 0.80 to 13.22 for the range of cell sensitivities investigated, with single fraction doses of 10.0-20.0 Gy. Optimization studies showed no significant dependence of therapeutic gain on hole spacing. CONCLUSION: With high, single-fraction doses, grid irradiation revealed a therapeutic advantage over uniform dose irradiation whenever the tumor and surrounding normal tissues cells were equally radiosensitive, or, particularly, if the tumor cells were more radioresistant than the normal cells. The therapeutic gain did not appear to be a strong function of grid design. This article was published in Int J Radiat Oncol Biol Phys and referenced in Journal of Cancer Science & Therapy

Relevant Expert PPTs

Relevant Speaker PPTs

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version